'Use of micro-ribonucleic acid (miRNA) to diagnose transplant rejection and tolerance of immunosuppression therapy' in Patent Application Approval Process (USPTO 20240285200)

Source :: Medical Patent Business Week. September 20, 2024, 3683
Publication Year :: 2024
Abstract: 2024 SEP 20 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- A patent application by the inventors CHANG, Bao-Li (Paoli, PA, US); GUETTOUCHE, Toumy [...]

Subjects :: Transplantation of organs, tissues, etc.
Immunotherapy
MicroRNA
B cells
Business
Health

Tools